¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"leukocyte count, total"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • total anodontia
    ¿ÏÀü¹«Ä¡¾ÆÁõ
  • total aphasia
    (¢¡global aphasia) ¿ÏÀü¾ð¾î»ó½ÇÁõ
  • total blindness
    ¿ÏÀü½Ã°¢»ó½Ç, ¿ÏÀü½Ç¸í
  • total color blindness
    ¿ÏÀü»ö°¢»ó½Ç, ¿ÏÀü»ö¸Í
  • total cataract
    ¿ÏÀü¹é³»Àå
  • total cleavage
    (¢¡holoblastic cleavage) ¿ÂºÐÇÒ, ÀüüºÐÇÒ
  • total cystectomy
    ¹æ±¤¸ðµÎÀýÁ¦¼ú
  • total lung capacity
    ÀüÆó¿ë·®, ¿ÂÇãÆÄ¿ë·®
  • total organic carbon
    ÃÑÀ¯±âź¼Ò
  • total deafness
    ¿ÏÀü±Í¸ÔÀ½
  • total oxygen demand
    ¿Â»ê¼Ò¿ä±¸·®
  • total potential energy difference
    ÃÑÀ§Ä¡¿¡³ÊÁöÂ÷
  • total extirpation
    ¿ÏÀüÀûÃâ¼ú
  • total gastrectomy
    ¿ÂÀ§ÀýÁ¦(¼ú), À§ÀüÀýÁ¦(¼ú)
  • total glossectomy
    ¿ÂÇôÀýÁ¦¼ú, ¿ÏÀüÇôÀýÁ¦¼ú
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • class I human leukocyte antigen
    Á¦ 1±Þ ÀÎü¹éÇ÷±¸Ç׿ø
  • class II human leukocyte antigen
    Á¦ 2±Þ ÀÎü¹éÇ÷±¸Ç׿ø
  • contracted leukocyte
    ¼öÃà¹éÇ÷±¸
  • endothelial leukocyte
    ³»ÇǼº ¹éÇ÷±¸(?ËÑÌ´Ë´).
  • endothelial leukocyte adhesion molecule
    ³»ÇǼ¼Æ÷¹éÇ÷±¸ À¯ÂøºÐÀÚ
  • eosinophil leukocyte
    »êÈ£¼º ¹éÇ÷±¸(¡­ÛÜúìϹ).ÀÇÈ£»ê¼º ¹éÇ÷±¸.
  • eosinophil leukocyte
    »êÈ£¼º ¹éÇ÷±¸(?ËÑÌ´Ë´).[ÀÇ]È£»ê¼º ¹éÇ÷±¸.
  • eosinophilic leukocyte
    È£»ê¼º¹éÇ÷±¸
  • globular leukocyte
    ±¸»ó¹éÇ÷±¸(Ë´Ë×ËÑÌ´Ë´).
  • globule leukocyte
    µÕ±Ù°ú¸³¹é¼¼Æ÷
  • granular leukocyte
    °ú¸³¹éÇ÷±¸
  • heterophile leukocyte
    ÀÌ¿°¼º ¹éÇ÷__ì£æøàõÛÜúìϹ).
  • human leukocyte antigen
    Àΰ£ ¹éÇ÷±¸ Ç׿ø
  • human leukocyte antigen
    ÀÎü¹éÇ÷±¸Ç׿ø.
  • human leukocyte antigen
    ÀÎü¹éÇ÷±¸Ç׿ø.
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 4
TABC total aerobic bacteria count; typhoid, paratyphoid A, paratyphoid B, and paratyphoid C [vaccine]
TCR T-cell reactivity; T-cell receptor; T-cell rosette; thalamocortical relay; total cytoplasmic ribosom...
TWD total white and differential [cell count]
TA alkaline tuberculin; arterial tension; axillary temperature; tactile afferent; Takayasu arteritis; t...
TAC tachykinin; terminal antrum contraction; tetracaine, adrenalin, and cocaine; time-activity curve; to...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 4
HLE Human Leukocyte Elastase
HLA-DR Human leukocyte antigen
HLI Human leukocyte interferon
LAR Leukocyte Common Antigen-Related
LFA-1 Leukocyte Function Antigen-1
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • total elasticity of muscle
    ±ÙÀ° ÃÑ Åº¼º
  • total extirpation
    Àü ÀûÃâ, Àü ÀûÃâ¼ú
  • total fatty acids
    ÃÑ Áö¹æ»ê
  • total flow
    ÃÑ À¯·®, Àüü À¯·®
  • total gastrectomy
    À§ ÀüÀýÁ¦, À§ ÀüÀýÁ¦¼ú
  • total growth
    ÃÑ Áõ½Ä·®
  • total hematuria
    Àü Ç÷´¢Áõ
  • total hyperplasia
    Àüü °ú´Ù Çü¼º
  • total hysterectomy
    Àü Àڱà ÀýÁ¦¼ú
  • total inversion
    Àüü ÀÚ¸®¹Ù²Þ
  • total irradiation
    Àü½Å Á¶»ç
  • total laryngectomy
    ÈĵΠÀü ÀûÃâ¼ú
  • total lymphoid irradiation
    Àü ¸²ÇÁ Á¶»ç
  • total nephrectomy
    ½Å Àü ÀýÁ¦, ½Å Àü ÀýÁ¦¼ú
  • total nerve block
    ¿ÏÀü Àü´Þ ¸¶Ãë
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
polymorphonuclear leukocyte Small, actively motile white blood cells containing many lysosomes and specialising in phagocytosis.
(09 Oct 1997)
cystinotic leukocyte A leukocyte having an enhanced content of cystine, found in patients with disorders characterised by the storage of cystine; within the leukocyte, the cystine, largely in noncrystalline form, is associated with dense lysosomal particles.
(05 Mar 2000)
segmented leukocyte Any mature polymorphonuclear leukocyte, especially a neutrophilic leukocyte.
(05 Mar 2000)
human leukocyte antigen <immunology> A genetic fingerprint on white blood cells and platelets, composed of proteins that play a critical role in activating the bodys immune system to respond to foreign organisms.
Acronym: HLA
(16 Dec 1997)
human leukocyte-associated antigens Proteins on the outer part of body cells that help fight illness. These proteins vary from person to person. Scientists think that people with certain types of HLA antigens are more likely to develop insulin-dependent diabetes.The HLA antigens are also responsible for histocompatibility reactions.
(09 Oct 1997)
hyaline leukocyte Old term for a monocyte, and for a mononuclear macrophage in various lesions.
(05 Mar 2000)
neutrophilic leukocyte A neutrophilic granulocyte, the most frequent of the polymorphonuclear leukocyte's, and also the most active phagocyte among the various types of white blood cells; when treated with Wright's stain (or similar preparations), the fairly abundant cytoplasm is faintly pink, and numerous tiny, slightly refractile, relatively bright pink or violet-pink, diffusely scattered granules are recognizable in the cytoplasm; the deeply stained blue or purple-blue nucleus is sharply distinguished from the cytoplasm and is distinctly lobated, with thin strands of chromatin connecting the three to five lobes.
(05 Mar 2000)
nonfilament polymorphonuclear leukocyte <haematology> A neutrophil, basophil, or eosinophil that is not completely matured, i.e., the lobes of the nuclei remain connected with bands of chromatin, in contrast to the thin strands observed in mature cells.
(05 Mar 2000)
nongranular leukocyte <haematology> A general, non-specific term frequently used with reference to lymphocytes, monocytes, and plasma cells; although the cytoplasm of a lymphocyte or monocyte contains tiny granules, it is nongranular in comparison with that of a neutrophil, basophil, or eosinophil.
See: leukocyte.
Synonym: agranular leukocyte.
(05 Mar 2000)
nonmotile leukocyte <haematology> A term sometimes used with reference to lymphocytes, monocytes, and plasma cells; although such forms actually have some degree of motility, they are nonmotile in comparison with the actively ameboid, neutrophilic, basophilic, and eosinophilic leukocyte's.
(05 Mar 2000)
oxyphilic leukocyte A polymorphonuclear leukocyte characterised by many large or prominent, refractile, cytoplasmic granules that are fairly uniform in size and bright yellow-red or orange when treated with Wright's or similar stains; the nuclei are usually larger than those of neutrophils, do not stain as deeply, and characteristically have two lobes (a third lobe is sometimes interposed on the connecting strand of chromatin); these leukocyte's are motile phagocytes with distinctive antiparasitic functions.
Synonym: acidophilic leukocyte, eosinocyte, eosinophil, eosinophile, oxyphil, oxyphile, oxyphilic leukocyte.
(05 Mar 2000)
transitional leukocyte Old term for a monocyte.
(05 Mar 2000)
endothelial leukocyte Old term for a monocyte, a type of leukocyte thought to be derived from reticuloendothelial tissue.
(05 Mar 2000)
endothelial-leukocyte adhesion molecule 115,000 Mw molecule on the surface of endothelial cells that is involved in blood leukocyte attachment to vessel walls as well as emigration from the vessels into the tissues.
(05 Mar 2000)
eosinophilic leukocyte A polymorphonuclear leukocyte characterised by many large or prominent, refractile, cytoplasmic granules that are fairly uniform in size and bright yellow-red or orange when treated with Wright's or similar stains; the nuclei are usually larger than those of neutrophils, do not stain as deeply, and characteristically have two lobes (a third lobe is sometimes interposed on the connecting strand of chromatin); these leukocyte's are motile phagocytes with distinctive antiparasitic functions.
Synonym: acidophilic leukocyte, eosinocyte, eosinophil, eosinophile, oxyphil, oxyphile, oxyphilic leukocyte.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 4
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 4
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 4
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 4
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 4
ÅëÇÕ°Ë»ö ¿Ï·á